Tibioperoneal bypass for popliteal arterial occlusion

Area of Science:

• Vascular Surgery
• Peripheral Arterial Disease
• Surgical Outcomes

Background:

• Chronic arterial occlusive disease can significantly impact lower limb circulation.
• Popliteal artery occlusion (OPA) presents unique challenges in treatment.
• Distinguishing OPA from more extensive femoropopliteal occlusive disease (OFPA) is crucial for surgical planning.

Purpose of the Study:

• To define the clinical characteristics of chronic arterial occlusive disease primarily affecting the popliteal artery (OPA).
• To evaluate the efficacy and long-term outcomes of tibioperoneal bypass in patients with OPA.
• To compare outcomes between OPA and OFPA patient groups.

Main Methods:

• Retrospective study of 56 patients undergoing tibioperoneal bypass using reversed saphenous veins.
• Patients were categorized into OPA (31) and OFPA (25) groups.
• Follow-up ranged from 1 to 163 months, assessing graft patency and arteriographic findings.

Main Results:

• Buerger's disease was more prevalent in the OPA group (49%), while arteriosclerosis obliterans dominated the OFPA group (64%).
• Three-year primary and secondary graft patency rates for OPA were 72% and 85%, comparable to OFPA.
• No significant progression of occlusive disease in the inflow artery was observed post-surgery.

Conclusions:

• Popliteal-distal bypass is a dependable surgical option for carefully selected patients with OPA.
• The procedure yields favorable long-term graft patency, similar to cases with more extensive occlusive disease.
• This surgical approach effectively manages OPA without exacerbating proximal arterial disease.